These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1290 related articles for article (PubMed ID: 33521772)

  • 1. Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis.
    Bramante CT; Ingraham NE; Murray TA; Marmor S; Hovertsen S; Gronski J; McNeil C; Feng R; Guzman G; Abdelwahab N; King S; Tamariz L; Meehan T; Pendleton KM; Benson B; Vojta D; Tignanelli CJ
    Lancet Healthy Longev; 2021 Jan; 2(1):e34-e41. PubMed ID: 33521772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19.
    Bramante CT; Ingraham NE; Murray TA; Marmor S; Hovertsen S; Gronski J; McNeil C; Feng R; Guzman G; Abdelwahab N; King S; Meehan T; Pendleton KM; Benson B; Vojta D; Tignanelli CJ
    medRxiv; 2020 Jun; ():. PubMed ID: 32607520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study.
    Gao M; Piernas C; Astbury NM; Hippisley-Cox J; O'Rahilly S; Aveyard P; Jebb SA
    Lancet Diabetes Endocrinol; 2021 Jun; 9(6):350-359. PubMed ID: 33932335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis.
    Ma Z; Krishnamurthy M
    PLoS One; 2023; 18(2):e0282210. PubMed ID: 36821577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preadmission usage of metformin and mortality in COVID-19 patients including the post-discharge period.
    Saygili ES; Karakiliç E; Mert E; Şener A; Mirci A
    Ir J Med Sci; 2022 Apr; 191(2):569-575. PubMed ID: 34713419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.
    Hung SC; Chang YK; Liu JS; Kuo KL; Chen YH; Hsu CC; Tarng DC
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):605-14. PubMed ID: 26094107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysis.
    Teague TT; Payne SR; Kelly BT; Dempsey TM; McCoy RG; Sangaralingham LR; Limper AH
    Respir Res; 2022 Apr; 23(1):91. PubMed ID: 35410255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes.
    Crouse AB; Grimes T; Li P; Might M; Ovalle F; Shalev A
    Front Endocrinol (Lausanne); 2020; 11():600439. PubMed ID: 33519709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative.
    Andersen KM; Bates BA; Rashidi ES; Olex AL; Mannon RB; Patel RC; Singh J; Sun J; Auwaerter PG; Ng DK; Segal JB; Garibaldi BT; Mehta HB; Alexander GC;
    Lancet Rheumatol; 2022 Jan; 4(1):e33-e41. PubMed ID: 34806036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with Obesity and a History of Metformin Treatment Have Lower Influenza Mortality: A Retrospective Cohort Study.
    Cummings TH; Magagnoli J; Hardin JW; Sutton SS
    Pathogens; 2022 Feb; 11(2):. PubMed ID: 35215211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin versus sulphonylureas for new onset atrial fibrillation and stroke in type 2 diabetes mellitus: a population-based study.
    Zhou J; Zhang G; Chang C; Chou OHI; Lee S; Leung KSK; Wong WT; Liu T; Wai AKC; Cheng SH; Zhang Q; Tse G
    Acta Diabetol; 2022 May; 59(5):697-709. PubMed ID: 35112189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Metformin Initiation and Risk of Asthma Exacerbation. A Claims-based Cohort Study.
    Wu TD; Keet CA; Fawzy A; Segal JB; Brigham EP; McCormack MC
    Ann Am Thorac Soc; 2019 Dec; 16(12):1527-1533. PubMed ID: 31415212
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study.
    Jiang N; Chen Z; Liu L; Yin X; Yang H; Tan X; Wang J; Li H; Tian M; Lu Z; Xiong N; Gong Y
    Diabetes Res Clin Pract; 2021 Mar; 173():108619. PubMed ID: 33310173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.
    Shi Q; Zhang X; Jiang F; Zhang X; Hu N; Bimu C; Feng J; Yan S; Guan Y; Xu D; He G; Chen C; Xiong X; Liu L; Li H; Tao J; Peng Z; Wang W
    Diabetes Care; 2020 Jul; 43(7):1382-1391. PubMed ID: 32409504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis.
    Jong CB; Chen KY; Hsieh MY; Su FY; Wu CC; Voon WC; Hsieh IC; Shyu KG; Chong JT; Lin WS; Hsu CN; Ueng KC; Lai CL
    Int J Cardiol; 2019 Sep; 291():152-157. PubMed ID: 30905518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy.
    Ojeda-Fernández L; Foresta A; Macaluso G; Colacioppo P; Tettamanti M; Zambon A; Genovese S; Fortino I; Leoni O; Roncaglioni MC; Baviera M
    Diabetes Obes Metab; 2022 May; 24(5):891-898. PubMed ID: 35014746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Preoperative Metformin Exposure and Postoperative Outcomes in Adults With Type 2 Diabetes.
    Reitz KM; Marroquin OC; Zenati MS; Kennedy J; Korytkowski M; Tzeng E; Koscum S; Newhouse D; Garcia RM; Vates J; Billiar TR; Zuckerbraun BS; Simmons RL; Shapiro S; Seymour CW; Angus DC; Rosengart MR; Neal MD
    JAMA Surg; 2020 Jun; 155(6):e200416. PubMed ID: 32267474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes.
    Wang J; Cooper JM; Gokhale K; Acosta-Mena D; Dhalla S; Byne N; Chandan JS; Anand A; Okoth K; Subramanian A; Bangash MN; Jackson T; Zemedikun D; Taverner T; Hanif W; Ghosh S; Narendran P; Toulis KA; Tahrani AA; Surenthirakumaran R; Adderley NJ; Haroon S; Khunti K; Sainsbury C; Thomas GN; Nirantharakumar K
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1255-1268. PubMed ID: 33560344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.